- Home
- PKST vs FDMT Comparison
PKST vs FDMT Comparison
Compare PKST & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKST
- FDMT
- Stock Information
- Founded
- PKST 2008
- FDMT 2013
- Country
- PKST United States
- FDMT United States
- Employees
- PKST N/A
- FDMT N/A
- Industry
- PKST Real Estate Investment Trusts
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- PKST Real Estate
- FDMT Health Care
- Exchange
- PKST Nasdaq
- FDMT Nasdaq
- Market Cap
- PKST 483.8M
- FDMT 420.7M
- IPO Year
- PKST N/A
- FDMT 2020
- Fundamental
- Price
- PKST $12.74
- FDMT $7.99
- Analyst Decision
- PKST Hold
- FDMT Strong Buy
- Analyst Count
- PKST 1
- FDMT 9
- Target Price
- PKST $15.00
- FDMT $46.75
- AVG Volume (30 Days)
- PKST 153.0K
- FDMT 769.3K
- Earning Date
- PKST 10-30-2024
- FDMT 11-13-2024
- Dividend Yield
- PKST 7.01%
- FDMT N/A
- EPS Growth
- PKST N/A
- FDMT N/A
- EPS
- PKST N/A
- FDMT N/A
- Revenue
- PKST $233,198,000.00
- FDMT $17,000.00
- Revenue This Year
- PKST N/A
- FDMT N/A
- Revenue Next Year
- PKST $4.00
- FDMT $57.85
- P/E Ratio
- PKST N/A
- FDMT N/A
- Revenue Growth
- PKST 11.21
- FDMT N/A
- 52 Week Low
- PKST $9.89
- FDMT $7.32
- 52 Week High
- PKST $21.73
- FDMT $36.25
- Technical
- Relative Strength Index (RSI)
- PKST 40.27
- FDMT 40.80
- Support Level
- PKST $12.45
- FDMT $8.04
- Resistance Level
- PKST $13.22
- FDMT $8.96
- Average True Range (ATR)
- PKST 0.64
- FDMT 0.60
- MACD
- PKST -0.07
- FDMT 0.16
- Stochastic Oscillator
- PKST 13.32
- FDMT 36.02
About PKST Peakstone Realty Trust
Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets totaling approximately 19 million square feet across 24 states in majorly high-growth coastal and sunbelt markets.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.